ADCT
Price
$3.53
Change
+$0.03 (+0.86%)
Updated
Dec 24 closing price
Capitalization
437.29M
76 days until earnings call
Intraday BUY SELL Signals
RGNX
Price
$14.46
Change
+$0.11 (+0.77%)
Updated
Dec 24 closing price
Capitalization
732.01M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADCT vs RGNX

Header iconADCT vs RGNX Comparison
Open Charts ADCT vs RGNXBanner chart's image
ADC Therapeutics SA
Price$3.53
Change+$0.03 (+0.86%)
Volume$392.47K
Capitalization437.29M
REGENXBIO
Price$14.46
Change+$0.11 (+0.77%)
Volume$191.16K
Capitalization732.01M
ADCT vs RGNX Comparison Chart in %
ADCT
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADCT vs. RGNX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ADCT: $3.53 vs. RGNX: $14.46)
Brand notoriety: ADCT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 31% vs. RGNX: 31%
Market capitalization -- ADCT: $437.29M vs. RGNX: $732.01M
ADCT [@Biotechnology] is valued at $437.29M. RGNX’s [@Biotechnology] market capitalization is $732.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 1 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • ADCT’s FA Score: 1 green, 4 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADCT and RGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while RGNX’s TA Score has 5 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 6 bearish.
  • RGNX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than ADCT.

Price Growth

ADCT (@Biotechnology) experienced а -3.81% price change this week, while RGNX (@Biotechnology) price change was +9.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

ADCT is expected to report earnings on Mar 12, 2026.

RGNX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($732M) has a higher market cap than ADCT($437M). RGNX YTD gains are higher at: 87.063 vs. ADCT (77.387). ADCT has higher annual earnings (EBITDA): -112.75M vs. RGNX (-120M). RGNX has more cash in the bank: 274M vs. ADCT (235M). RGNX has less debt than ADCT: RGNX (76.5M) vs ADCT (117M). RGNX has higher revenues than ADCT: RGNX (161M) vs ADCT (75.2M).
ADCTRGNXADCT / RGNX
Capitalization437M732M60%
EBITDA-112.75M-120M94%
Gain YTD77.38787.06389%
P/E RatioN/AN/A-
Revenue75.2M161M47%
Total Cash235M274M86%
Total Debt117M76.5M153%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTRGNX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSGAX24.650.08
+0.33%
Columbia Cornerstone Equity A
STVYX15.270.05
+0.33%
SEI Tax-Managed Mgd Volatility Y (SIMT)
TVOAX42.810.12
+0.28%
Touchstone Small Cap Value A
PNOYX142.070.30
+0.21%
Putnam Sustainable Leaders Y
CLPFX13.99N/A
N/A
Catalyst Nasdaq-100 Hedged Equity I

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CLRB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+0.86%
CLRB - ADCT
41%
Loosely correlated
+2.60%
QTTB - ADCT
41%
Loosely correlated
+2.56%
NUVL - ADCT
40%
Loosely correlated
+0.89%
RGNX - ADCT
39%
Loosely correlated
+0.77%
IMTX - ADCT
37%
Loosely correlated
+1.47%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with VYGR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then VYGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
+0.77%
VYGR - RGNX
56%
Loosely correlated
+2.01%
SYRE - RGNX
56%
Loosely correlated
-0.54%
BEAM - RGNX
55%
Loosely correlated
+1.33%
DNLI - RGNX
53%
Loosely correlated
+1.07%
XNCR - RGNX
53%
Loosely correlated
-0.13%
More